Harbour BioMed Partners With Bristol Myers Squibb to Develop Next-Gen Antibody Therapies

source:

[1] Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies (https://finance.yahoo.com/news/harbour-biomed ...)

Harbour BioMed Partners With Bristol Myers Squibb to Develop Next-Gen Antibody Therapies

Related News

Babcock & Wilcox Secures $40M Refinery Contract

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes